retatrutide type 2 diabetes phase 2 trial results 2024 💉 may be redefining obesity treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Lilly's triple agonist achieves 16.8%

M.CocoR.Le BretonA.PratV

As we navigate through life, many of us seek effective ways to enhance our health, improve our skin, and boost our immune systems

2020;319:L422L434

It is such a sad thing to sit next to my loved one, and she'll say to me, "I know my brain's not working right." Like, she knows enough to know that she's not processing information in a way that she used to and it's really disappointing and upsetting, and it's devastating quite honestly, because she's a lovely person, but she's not who she was before because of this progressive neurocognitive decline

PUFA-PE production depends on coordinated action between acyl coenzyme A synthetase long-chain family member 4 (ACSL4) and lysophospholipid acyltransferase 3 (LPCAT3), which collectively activate and incorporate PUFAs (e.g., docosahexaenoic acid, arachidonic acid) into membrane lipids (43)